Zusammenfassung
Dieses Kapitel stellt, orientiert an klinischen Leitsymptomen, die sich bei glomerulären Erkrankungen als nephritisches oder nephrotisches Syndrom bzw. einem Mischbild zeigen, entsprechende Erkrankungen mit ihren Spezifika im Kindesalter dar. Die Möglichkeiten und Erkenntnisse genetischer Diagnostik und deren Bedeutung für die Therapie werden repetitiv aufgegriffen. Ebenso wird die Bedeutung des Komplementsystems als primärer Auslöser sowie sekundärer Aktivator glomerulärer Erkrankungen dargestellt.
Die Original-Version dieses Kapitels wurde korrigiert. http://dx.doi.org/10.1007/978-3-662-48789-1_19
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Von: Anja K. Büscher, Stefanie Weber
- 2.
Von Martin Pohl
Literatur
Arbeitsgemeinschaft für Pädiatrische Nephrologie (APN) (2007) Therapieempfehlung zur Lupusnephritis bei Kindern und Jugendlichen. Monatsschr Kinderheilkd 155: 1175–1188
Benz MR, Ehren R, Tönshoff V, Weber LT (2015) Alternativen zur Steroidbehandlung des steroidsensiblen nephrotischen Syndroms im Kindesalter. Nephrologe 10: 462–470
Benz MR, Reiter K, Eife R (2004) Hämaturie und Proteinurie im Kindesalter. Monatsschr. Kinderheilkd 152: 238–247
Benz MR, Weber LT (2012) Nephrotisches Syndrom im Kindesalter. Monatsschr Kinderheilkd 160: 787–804
Cossey LN, Walker PD, Larsen CP (2013) Phospholipase A2 receptor staining in pediatric idiopathic membranous glomerulopathy. Pediatr Nephrol 28: 2307–2311
Cugno M, Castelli R, Cicardi M (2008) Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation. Autoimmunity reviews 8: 156–159
Fries JW, Mendrick DL, Rennke HG (1988) Determinants of immune complex-mediated glomerulonephritis. Kidney Int 34: 333
Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR (2002) Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360: 1197–1202
Gbadegesin R, Smoyer WE (2008) Nephrotic Syndrome. In: Geary DF, Schaefer F (eds) Comprehensive Pediatric Nephrology. Mosby Elsevier, Philadelphia
Habbig S, Mihatsch MJ, Heinen S et al. (2009) C3 deposition glomerulopathy due to a functional factor H defect. Kidney international 75: 1230–1234
Hagelberg S, Lee Y, Bargman J et al. (2002) Longterm Followup of Childhood Lupus Nephritis. J Rheumatol 29: 2635–2642
Hanly JG, O’Keeffe AG, Su L et al. (2016) The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology 55: 252–262
KDIGO Clinical Practice Guideline for Glomerulonephritis (2012) Idiopathic membranous nephropathy. Kidney International Supplements 2: 186–197
KDIGO Glomerulonephritis Work Group (2012) KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2: 139–274
Legendre CM, Licht C, Muus P et al. (2013) Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 368 2169–2181
Lemaire M, Fremeaux-Bacchi V, Schaefer F et al. (2013) Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. Nat Genet 45: 531–536
Livingston B, Bonner A, Pope J (2011) Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis. Lupus 20: 1345–1355
Loirat C, Fakhouri F, Ariceta G et al. for HUSI (2016) An international consensus approach to the management of atypical hemolytic uremic syndrome in children. Pediatric nephrology 31: 15–39
Loirat C, Fremeaux-Bacchi V (2011) Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 6: 60
Mahler M, van Schaarenburg RA, Trouw LA (2013) Anti-C1q autoantibodies, novel tests, and clinical consequences. Frontiers in immunology 4: 117
McCaffrey J, Lennon R, Webb NJA (2015) The non-immunosuppressive management of childhood nephrotic syndrome. Pediatr Nephrol: http://link.springer.com/article/10.1007%2Fs00467-015-3241-0. Letzter Zugriff: 26.04.2016
Mekahli D, Liutkus A, Ranchin B et al. (2009) Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study. Pediatr Nephrol 24: 1525–1532
Menon S, Valentini RP (2010) Membranous nephropathy in children: clinical presentation and therapeutic approach. Pediatr Nephrol 25: 1419–1428
Mestecky J, Raska M, Julian BA et al. (2013) IgA Nephropathy: Molecular Mechanisms of the Disease Annu Rev Pathol Mech Dis 8: 217–240
Michael M, Elliott EJ, Craig JC, Ridley G, Hodson EM (2009) Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials. Am J Kidney Dis 53: 259–272
Mollnes TE, Kirschfink M (2006) Complement analysis in clinic and research. Advances in experimental medicine and biology 586: 361–380
Narchi H (2005) Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 90: 916–920
Niaudet P (2008) Nephritic Syndrome. In: Geary DF, Schaefer F (eds) Comprehensive Pediatric Nehrology. Mosby, Philadelphia
Noris M, Remuzzi G (2013) Overview of complement activation and regulation. Seminars in nephrology 33: 479–492
Pohl M, DittrichK, Ehrich JHH et al; Gesellschaft für Pädiatrische Nephrologie (2013) Behandlung der Purpura-Schönlein-Henoch-Nephritis bei Kindern und Jugendlichen – Therapieempfehlungen der Gesellschaft für Pädiatrische Nephrologie (GPN). Monatsschr Kinderheilkd 161: 543–553
Pons-Estel GJ, Alarcon GS, McGwin G Jr et al. (2009) Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Rheum 61: 830–839
Ponticelli C, Moroni M, Glassock RJ (2014) De Novo Glomerular Diseases after Renal Transplantation. Clin J Am Soc Nephrol 9: 1479–1487
Potter EV, Lipschultz SA, Abidh S, et al. (1982)Twelve to seventeen-year follow-up of patients with poststreptococcal acute glomerulonephritis in Trinidad. N Engl J Med 307: 725
Riedl M, Fakhouri F, Lequintrec M et al. (2014) The spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches. Semin Thromb Hemost 40: 444–464
Roberts IS, Cook HT, Troyanov S et al; Working Group of the International IgA Nephropathy Network and the Renal Pathology Society (2009) The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76: 546–556
Rodriguez-Iturbe B, Batsford S (2007) Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int 71: 1094
Rodriguez-Iturbe B, Musser JM (2008) The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol 19: 1855
Ronco P, Debiec H (2015) Pathophysiological advances in membranous nephropathy: time for a shift in patient’s care. Lancet 385: 1983–1992
Rosales A, Hofer J, Zimmerhackl LB et al. for the German-Austrian HUSSG (2012) Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis 54: 1413–1421
Rosenecker J (2014) Pädiatrische Differenzialdiagnostik. Springer, Berlin Heidelberg
Roy S 3rd, Murphy WM, Arant BS Jr. (1981) Poststreptococcal crescentic glomerulonephritis in children: comparison of quintuple therapy versus supportive care. J Pediatr 98: 403
Ruggenenti P, Debiec H, Ruggiero B et al. (2015) Anti-phospholipase A2 receptor antibody titer predicts post-rituximab outcome ofmembranous nephropathy. J Am Soc Nephrol 26: 2545–2558
Samuel S, Bitzan M, Zappitelli M et al. (2014) Canadian Society of Nephrology Commentary oft he 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis: Management of Nephrotic Syndrome in Children. Am J Kidney Dis 63: 354–362
Schärer K, Mehls O (2002) Pädiatrische Nephrologie. Springer, Berlin Heidelberg
Servais A, Noel LH, Roumenina LT et al. (2012) Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney international 82: 454–464
Siddall EC, Radhakrishnan J (2012) The pathophysiology of edema formation in the nephrotic syndrome. Kidney International 82: 635–642
Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC; Toronto Glomerulonephritis Registry Group (2004) Idiopathic membranous nephropathy: definition and relevance of a partial remission. Kidney Int 66: 1199–1205
Vivarelli M, Emma F (2014) Treatment of C3G with complement blockers. Semin Thromb Hemost 40: 472–477
Weening JJ, D’Agati VD, Schwartz MM et al. (2004) International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis: The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65: 521–530
Wilhelmus S, Bajema IM, Bertsias GK et al. (2015) Lupus nephritis management guidelines compared. Nephrol Dial Transplant (online first): 10.1093/ndt/gfv102
Wuerzner R, Riedl M, Rosales A, Orth-Hoeller D (2014) Treatment of enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Semin Thromb Hemost 40: 508–516
Zuber J, Fakhouri F, Roumenina LT, Loirat C, Fremeaux-Bacchi V (2012) Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nature Reviews Nephrology 8: 643–657
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer-Verlag GmbH Deutschland
About this chapter
Cite this chapter
Amann, K. et al. (2017). Glomeruläre Erkrankungen. In: Dötsch, J., Weber, L. (eds) Nierenerkrankungen im Kindes- und Jugendalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-48789-1_2
Download citation
DOI: https://doi.org/10.1007/978-3-662-48789-1_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-48788-4
Online ISBN: 978-3-662-48789-1
eBook Packages: Medicine (German Language)